BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PBOA - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://pharma-bio.org
X-WR-CALDESC:Events for PBOA
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20140101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20150421T090000
DTEND;TZID=UTC:20150423T150000
DTSTAMP:20260607T231818
CREATED:20150126T184823Z
LAST-MODIFIED:20150416T201203Z
UID:7910-1429606800-1429801200@pharma-bio.org
SUMMARY:INTERPHEX 2015
DESCRIPTION:PBOA will have a booth at INTERPHEX 2015! Please contact us to set up an appointment. \nPBOA is also sponsoring several sessions at INTERPHEX: \n\n\nThe Road to the Biologic IND\nCDMO Executive Perspectives\nQuality Agreements Panel\n\n\nMany of our member companies will be exhibiting at INTERPHEX:  \n\n\nPBOA – Booth 1044\nAAI Pharma Services / Cambridge Major Laboratories\, Inc. – Booth 1405\nCatalent Pharma Solutions – Booth 1546\nColdstream Laboratories\, Inc. – Booth 1136\nCook Pharmica – Booth 1245\nDPT Laboratories / Confab – Booth 1108\nHalo Pharmaceutical – Booth 1225\nHospira One 2 One™ – Booth 1418\nJubilant HollisterStier – Booth 1830\nMetrics Contract Services – Booth 2365\nPatheon\, Inc. – Booth 1424\nTherapure BioManufacturing – Booth 1353\nWellSpring Pharma Services – Booth 1224
URL:https://pharma-bio.org/event/interphex-2015/
LOCATION:Jacob K. Javits Center\, 655 West 34th Street\, New York City\, NY\, 10001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20150421T131500
DTEND;TZID=UTC:20150421T140000
DTSTAMP:20260607T231818
CREATED:20150401T195121Z
LAST-MODIFIED:20150402T131827Z
UID:8012-1429622100-1429624800@pharma-bio.org
SUMMARY:INTERPHEX Presentation: The Road to the Biologic IND
DESCRIPTION:Presenter: Michiel Ultee • Principal Consultant\, Ulteemit BioConsulting\, LLC\nLocation: INTERPHEX Innovation Stage 2\, Exhibit Hall \nThe Biologic IND (Investigational New Drug) application is a critical\, early milestone in evaluating the safety and efficacy of a potential new biopharmaceutical. An approved IND allows a sponsoring company to take the next step in developing its product — evaluation in patients in carefully planned and phased clinical trials. The route to the IND\, however\, requires in-depth technical expertise in biopharmaceutical development\, manufacturing\, analytical and toxicological testing\, and regulatory areas. Many research-based companies seek the assistance of outside experts in these areas\, knowing the value of a new therapeutic will skyrocket once clinical safety and efficacy are established. This presentation will focus on the key steps needed to move down the road from discovery to successful IND submission. \nFor more information\, visit the INTERPHEX page for this session.
URL:https://pharma-bio.org/event/interphex-presentation-the-road-to-the-biologic-ind/
LOCATION:Jacob K. Javits Center\, 655 West 34th Street\, New York City\, NY\, 10001\, United States
END:VEVENT
END:VCALENDAR